Cancer Research

Jnana Therapeutics announces appointment of alum Joanne Kotz, Ph.D. as Chief Executive Officer

November 6, 2018

Joanne Kotze, PhD, Jnana TherapeuticsJnana Therapeutics today announced that UC Berkeley Chemistry alum Joanne Kotz, Ph.D., a company co-founder, has been named Chief Executive Officer. Dr. Kotz has served as Jnana's president since December 2017. For more information...

Smallest life forms have smallest working CRISPR system

October 18, 2018

Archaea bacteria with CRISPR systems.

An ancient group of microbes that contains some of the smallest life forms on Earth also has the smallest CRISPR gene-editing machinery discovered to date.

Five distinguished individuals to be honored with highest American Cancer Society Award

October 17, 2018

American Cancer Society LogoThe American Cancer Society will bestow its highest honor – the Medal of Honor – to five individuals on Oct. 18 in Washington DC. The Medal of Honor is awarded to distinguished individuals who have made valuable contributions in the fight against cancer. The 2018 recipients include the Honorable Joseph R. Biden Jr., for Cancer Control; Emmanuelle Charpentier, PhD, for Basic Research; Jennifer Doudna, PhD, for Basic Research; Charis Eng, MD, PhD, for Clinical Research; and Michael J. Thun MD, MS, for Cancer Control Science.

Doudna joins Biden during Bay Area stop on cancer ‘listening tour’

February 29, 2016

Jennifer DoudnaWhen Vice President Joe Biden dropped by UC San Francisco on Saturday for a wide-ranging discussion of the current state of cancer research, UC Berkeley’s Jennifer Doudna was on hand to emphasize the need to fund basic research as well as clinical research.

Bergman wins Welch Award

May 2, 2014
Chemistry Professor Robert Bergman has been named the 2014 recipient of the Welch Award in Chemical Research for “pioneering work in alkane activation and mechanisms of organometallic reactions.”

Doudna awarded Japan Prize for invention of CRISPR gene editing

February 2, 2017

Emmanuelle Charpentier, Jennifer Doudna receiving 2017 Japan PrizeJennifer Doudna and Emmanuelle Charpentier were awarded the Japan Prize today for their invention of the revolutionary gene-editing technology known as CRISPR-Cas9, which has swept into research labs around the world and is already yielding new therapies for cancer and hereditary diseases.

Finding Chemo

June 24, 2016

LiposomeTo help cancer drugs access tumors, Ting Xu and collaborators are making tiny particles called nanocarriers that protect the drugs during their journey to the tumor. Read the article.